Atlas Venture Opportunity Fund I, L.P. Dyne Therapeutics, Inc. (DYN) insider trading activity

Atlas Venture Opportunity Fund I, L.P. is of Dyne Therapeutics, Inc.. Currently has a direct ownership of 1.46 Million shares of DYN, which is worth approximately $35 Million. The most recent transaction as insider was on Mar 01, 2024, when has been sold 29,435 shares (Common Stock) at a price of $30.05 per share, resulting in proceeds of $884,521. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.46M

0% 3M change

n/a 12M change

Total Value Held $35 Million

Atlas Venture Opportunity Fund I, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 01 2024	SELL Open market or private sale	$884,521 $30.05 p/Share	29,435 Reduced 1.98%	1,458,691 Common Stock

Also insider at

DAWN

Day One Biopharmaceuticals, Inc. Healthcare

> 10% Shareholder

AVO